Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico

Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico

Background. The evolving pattern of HCV genotypes (GTs) and risk factors (RFs) in HCV-infected patients in Mexico is poorly understood. This study aimed to access the temporal trend of HCV GTs and RFs in HCV patients from two care centers.Material and methods. Chronic HCV patients [177 and 153 patie...

Full description

Bibliographic Details
Main Authors: Linda E. Muñoz-Espinosa, Maria E. Trujillo-Trujillo, Roberto F. Martínez-Macías, Arturo Panduro, Ana M. Rivas-Estilla, Nora A. Fierro, Ana L. Silvera-Linares, Rafael Torres-Valadez, Paula Cordero-Pérez, Karina González-Aldaco, Carlos Y. Chen-López, Alexis José-Abrego, Jaime R. Zuñiga-Noriega, Maria C. Gutiérrez-Ruiz, Sonia Roman, Ph.D.
Format: Article
Language:English
Published: Elsevier 2015-09-01
Series:Annals of Hepatology
Subjects:
HCV infection
Molecular epidemiology
Risk groups
Antiviral therapy
Cirrhosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119307586

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119307586

Similar Items